EP. 2 Evolving Practice Standards and Disease Progression Beyond Frontline Therapy for Patients with DLBCL
November 22nd, 2026Five Under 5: Top Oncology Videos for the Week of 11/20The top 5 OncLive TV videos of the week cover insights in NSCLC, HER2+ gastroesophageal cancer, low-grade glioma, HR+ breast cancer, and CML.Read more
November 21st, 2026The OncFive: Top Oncology Articles for the Week of 11/15The FDA approved giredestrant plus everolimus in ESR1-mutated breast cancer and neladalkib in ALK+ NSCLC, issued a CRL to ivonescimab, and more.Read more
November 20th, 2026OncLive Weekly News Quiz (11/20/2026): Did You Miss Crucial Lung Cancer, PCNSL, Gastroesophageal Cancer, and AML Updates?Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.Read more
November 18th, 2026Galinpepimut-S Improves OS in AML in Second or Later RemissionMaintenance galinpepimut-S extended overall survival in transplant-ineligible AML in second or later remission.Read more
November 10th, 2026Prizlon-Cel Nets FDA RMAT and Fast Track Designations in R/R LBCLThe anti-CD19/CD20 CAR T-cell therapy will be studied in the phase 2 ABZT-121 trial after progression on commercial CAR T-cell therapy.Read more
November 9th, 2026FDA Flashback: Hematologic Cancer Decisions and News From October 2026Read a refresh of hematologic cancer FDA news from October 2026, including the approval of a noncovalent BTK inhibitor in untreated CLL/SLL.Read more